
Sign up to save your podcasts
Or


The MS Prodrome :56
When is it appropriate to discontinue disease-modifying therapy in MS? 4:18
Study shows Masitinib slows disability progression in progressive MS 6:49
Multiple Sclerosis International Federation announces the Atlas of MS, with Clare Walton 9:08
Study shows disease-modifying therapy may delay disability progression and time until people with primary progressive MS need a wheelchair 20:55
Study analyzes benefits of Wahls Diet & Swank Diet 22:47
Atara BioTherapeutics shares initial data from its ATA-188 cell therapy clinical trial, with Dr. AJ Joshi 24:07
Share this episode 40:17
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/MSVirtual2020
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Give RealTalk MS a Rating and Review
National MS Society's Ask An MS Expert Video Replay
What You Need to Know About Coronavirus (COVID-19)
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating and Review
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode: Guests: Clare Walton, Dr. AJ Joshi
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSVirtual2020, RealTalkMS
Privacy Policy
By Jon Strum4.7
144144 ratings
The MS Prodrome :56
When is it appropriate to discontinue disease-modifying therapy in MS? 4:18
Study shows Masitinib slows disability progression in progressive MS 6:49
Multiple Sclerosis International Federation announces the Atlas of MS, with Clare Walton 9:08
Study shows disease-modifying therapy may delay disability progression and time until people with primary progressive MS need a wheelchair 20:55
Study analyzes benefits of Wahls Diet & Swank Diet 22:47
Atara BioTherapeutics shares initial data from its ATA-188 cell therapy clinical trial, with Dr. AJ Joshi 24:07
Share this episode 40:17
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/MSVirtual2020
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Give RealTalk MS a Rating and Review
National MS Society's Ask An MS Expert Video Replay
What You Need to Know About Coronavirus (COVID-19)
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating and Review
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode: Guests: Clare Walton, Dr. AJ Joshi
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSVirtual2020, RealTalkMS
Privacy Policy
6,663 Listeners

5,121 Listeners

16 Listeners

6,440 Listeners

9,231 Listeners

49 Listeners

32 Listeners

125 Listeners

1,458 Listeners

637 Listeners

114 Listeners

11,429 Listeners

1,150 Listeners

3,600 Listeners

165 Listeners